Is Platelet Reactivity a Therapeutic Target to Limit Microvascular Obstruction?

Is Platelet Reactivity a Therapeutic Target to Limit Microvascular Obstruction?

Bibliographic Details
Main Authors:	Jaclyn Carberry, Colin Berry
Format:	Article
Language:	English
Published:	Wiley 2022-02-01
Series:	Journal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Subjects:	Editorials adenosine di‐phosphate arachidonic acid dual antiplatelet therapy microvascular obstruction platelet aggregation
Online Access:	https://www.ahajournals.org/doi/10.1161/JAHA.121.024930

Similar Items

Post–ST‐Segment–Elevation Myocardial Infarction Platelet Reactivity Is Associated With the Extent of Microvascular Obstruction and Infarct Size as Determined by Cardiac Magnetic Resonance Imaging
by: Eias Massalha, et al.
Published: (2022-02-01)

Assesment of platelet antiaggregant activity of the ethanolic fraction obtained from the bark of Nectandra amazonum Nees.
by: Jenaro Antonio ESPITIA CORREDOR, et al.
Published: (2016-09-01)

Correlations among different platelet aggregation pathways in a group of healthy volunteers
by: Alejandro Carazo, et al.
Published: (2024-12-01)

To Have and Have Not: Intrinsic Platelet Hyperreactivity?
by: Marc Laine, et al.
Published: (2018-03-01)

Obstructive Sleep Apnea Affecting Platelet Reactivity in Patients Undergoing Percutaneous Coronary Intervention
by: Xiao-Min Jiang, et al.
Published: (2018-01-01)

Myeloproliferative Neoplasms and Aspirin: Does Increased Platelet Turnover Matter?
by: Ilgın Koçak Göktürk, et al.
Published: (2023-03-01)

Arachidonic acid causes lysis of blood cells and ADP-dependent platelet activation responses in platelet function tests
by: Sofia Ramström
Published: (2019-11-01)

Antiplatelet therapy in patients with myocardial infarction with non-obstructive coronary arteries: A clinical perspective
by: Wenjie Chen, et al.
Published: (2023-01-01)

Platelet aggregation, dyslipoproteinemia and polyunsaturated fatty acids
by: E. I. Sokolov, et al.
Published: (2006-10-01)

Impact of Obstructive Sleep Apnea on Platelet Function Profiles in Patients With Acute Coronary Syndrome Taking Dual Antiplatelet Therapy
by: Wei Gong, et al.
Published: (2018-08-01)

Platelet reactivity in patients with chronic kidney disease undergoing percutaneous coronary intervention
by: Pei Zhu, et al.
Published: (2019-10-01)

Effects of Body Mass Index and Body Weight on Plasma Concentration of Ticagrelor and Platelet Aggregation Rate in Patients with Unstable Angina in a Chinese Han Population
by: Houling Guo, et al.
Published: (2024-03-01)

Deferiprone, an iron chelator, alleviates platelet hyperactivity in patients with β-thalassaemia/HbE
by: Ngan Thi Tran, et al.
Published: (2022-12-01)

Coronary microvascular dysfunction. Diagnostics and therapy of non-obstructive coronary diseases
by: Ipoly Szauder
Published: (2024-08-01)

Regulation of Hypoxic–Adenosinergic Signaling by Estrogen: Implications for Microvascular Injury
by: Jessica Cassavaugh, et al.
Published: (2023-03-01)

The REFLO-STEMI (REperfusion Facilitated by LOcal adjunctive therapy in ST-Elevation Myocardial Infarction) trial: a randomised controlled trial comparing intracoronary administration of adenosine or sodium nitroprusside with control for attenuation of microvascular obstruction during primary percutaneous coronary intervention
by: Sheraz A Nazir, et al.
Published: (2016-12-01)

Development and clinical validation of a novel platelet count-based nomogram for predicting microvascular invasion in HCC
by: Wenjie Zheng, et al.
Published: (2025-02-01)

Ectonucleoside Triphosphate Diphosphohydrolase-1/CD39 Affects the Response to ADP of Female Rat Platelets
by: Elisabetta Caiazzo, et al.
Published: (2020-01-01)

Effects of novel quinoid thiosulfonate derivative on ADP-induced platelet aggregation
by: T. Halenova, et al.
Published: (2016-07-01)

The role of microvascular obstruction and intramyocardial hemorrhage in reperfusion injury to the heart
by: К. V. Zavadovsky, et al.
Published: (2024-04-01)

Sex differences in flow cytometry–based platelet reactivity in stable outpatients suspected of myocardial ischemia
by: Farahnaz Waissi, et al.
Published: (2020-07-01)

Aggregometry in the settings of thrombocytopenia, thrombocytosis and antiplatelet therapy
by: GianMarco Podda, et al.
Published: (2018-10-01)

<i>N</i>-Acetylcysteine Inhibits Platelet Function through the Regeneration of the Non-Oxidative Form of Albumin
by: Sonia Eligini, et al.
Published: (2022-02-01)

The Role of Microvascular Obstruction and Intra-Myocardial Hemorrhage in Reperfusion Cardiac Injury. Analysis of Clinical Data
by: Vyacheslav V. Ryabov, et al.
Published: (2024-03-01)

CMR of microvascular obstruction and hemorrhage in myocardial infarction
by: Wu Katherine C
Published: (2012-09-01)

Advances and Perspectives in methods for identifying high platelet reactivity
by: Hua Gao, et al.
Published: (2023-12-01)

Anti-Inflammatory and Antiplatelet Activities of Plasma Are Conserved Across Twelve Mammalian Species
by: Sagheer Ahmed, et al.
Published: (2014-07-01)

Increased fatigability and impaired skeletal muscle microvascular reactivity in adults with obstructive sleep apnea: a cross-sectional study
by: Shipra Puri, et al.
Published: (2024-10-01)

Impact of antiplatelet therapy on microvascular thrombosis during ST-elevation myocardial infarction
by: Sophia Khattak, et al.
Published: (2024-03-01)

Long-pulsed ultrasound-mediated microbubble thrombolysis in a rat model of microvascular obstruction
by: Wang Rui, et al.
Published: (2024-03-01)

Anti-Platelet Properties of Phenolic Extracts from the Leaves and Twigs of <i>Elaeagnus rhamnoides</i> (L.) A. Nelson
by: Bartosz Skalski, et al.
Published: (2019-10-01)

Increased platelet reactivity and platelet–leukocyte aggregation after elective coronary bypass surgery
by: Torbjörn Ivert, et al.
Published: (2019-11-01)

Aspirin nonsensitivity in patients with vascular disease: Assessment by light transmission aggregometry (aspirin nonsensitivity in vascular patients)
by: Hamzah Khan, et al.
Published: (2021-12-01)

SYNTHESIS, ANTIAGGREGATION AND ANTITROMBOTIC ACTIVITIES OF NEW DERIVATIVES OF HYDROXYBENZOIC ACIDS WITH TAURIC FRAGMENT
by: A. K. Brel, et al.
Published: (2021-08-01)

Reticulated platelets – a new risk factor of atherothrombosis?
by: S. G. Khaspekova, et al.
Published: (2021-07-01)

Post-thyroidectomy hypothyroidism increases the expression and activity of ectonucleotidases in platelets: Possible involvement of reactive oxygen species
by: Jucimara Baldissarelli, et al.
Published: (2018-11-01)

Arginine Vasopressin Plays a Role in Microvascular Dysfunction After ST‐Elevation Myocardial Infarction
by: Ayman Al‐Atta, et al.
Published: (2023-09-01)

Obstructive Sleep Apnea, Platelet Aggregation, and Cardiovascular Risk
by: Zanetta Kovbasyuk, et al.
Published: (2024-08-01)

Identification of Potential Drug Targets for Antiplatelet Therapy Specifically Targeting Platelets of Old Individuals through Proteomic Analysis
by: Seung Hee Lee, et al.
Published: (2023-10-01)

In Vitro Effect of Mitochondria-Targeted Triphenylphosphonium-Based Compounds (Honokiol, Lonidamine, and Atovaquone) on the Platelet Function and Cytotoxic Activity
by: Héctor Montecino-Garrido, et al.
Published: (2022-05-01)